MuRF-1 and Atrogin-1 Protein Expression and Quadriceps Fiber Size and Muscle Mass in Stable Patients with COPD
暂无分享,去创建一个
M. Polkey | W. Man | N. Hopkinson | J. Moxham | P. Kemp | J. Riddoch-Contreras | G. Marsh | S. Natanek | Paul R. Kemp
[1] M. Polkey,et al. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine? , 2013, Muscle & nerve.
[2] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[3] F. Maltais,et al. MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease. , 2012, Journal of applied physiology.
[4] M. Polkey,et al. p38 Mitogen-activated Protein Kinase is Not Activated in the Quadriceps of Patients with Stable Chronic Obstructive Pulmonary Disease , 2012, COPD.
[5] M. Polkey,et al. Quadriceps wasting and physical inactivity in patients with COPD , 2012, European Respiratory Journal.
[6] M. Polkey,et al. S49 Increased skeletal muscle-specific microRNA-1 in the blood of COPD patients , 2011, Thorax.
[7] M. Polkey,et al. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD , 2011, Thorax.
[8] E. Mercken,et al. Decreased exercise-induced expression of nuclear factor-κB-regulated genes in muscle of patients with COPD. , 2011, Chest.
[9] M. Polkey,et al. P143 NF-kappa B (NF-κB) and activator protein-1 (AP-1) DNA binding in the quadriceps of COPD patients , 2010, Thorax.
[10] D. Brooks,et al. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. , 2010, American journal of respiratory cell and molecular biology.
[11] R. Rabinovich,et al. Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients , 2010, Current opinion in pulmonary medicine.
[12] M. Polkey,et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity , 2009, European Respiratory Journal.
[13] S. Hussain,et al. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease , 2008, International journal of chronic obstructive pulmonary disease.
[14] C. Maganaris,et al. The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse , 2007, The Journal of physiology.
[15] B. Pedersen,et al. Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle. , 2007, American journal of physiology. Endocrinology and metabolism.
[16] A. Russell,et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[17] M. Polkey,et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease , 2007, Respiratory research.
[18] K. Meijer,et al. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. , 2007, American journal of physiology. Endocrinology and metabolism.
[19] R. Porcher,et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease , 2006, Thorax.
[20] Thierry Troosters,et al. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. , 2005, Archives of physical medicine and rehabilitation.
[21] J. Hankinson,et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.
[22] G. Viegi,et al. Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.
[23] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[24] D. Mann,et al. TNF‐α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] W. Frontera,et al. IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.
[26] M. Polkey,et al. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease , 2004, European Respiratory Journal.
[27] X. Busquets,et al. NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight , 2004, Thorax.
[28] W. Frontera,et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.
[29] M. Decramer,et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003, Thorax.
[30] Y. Lacasse,et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[31] Sally J. Singh,et al. Bedside methods versus dual energy X‐ray absorptiometry for body composition measurement in COPD , 2002, European Respiratory Journal.
[32] A. Russell,et al. UCP3 protein expression is lower in type I, IIa and IIx muscle fiber types of endurance-trained compared to untrained subjects , 2002, Pflügers Archiv.
[33] ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.
[34] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[35] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[36] M. Polkey,et al. Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man , 1995, Muscle & nerve.
[37] M. Rennie,et al. Measurement of human tissue protein synthesis: an optimal approach. , 1994, The American journal of physiology.
[38] E. Wouters,et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.
[39] M. Rennie,et al. Muscle protein turnover and the wasting due to injury and disease. , 1985, British medical bulletin.
[40] M. Rennie,et al. EFFECTS OF INJURY, DISEASE, AND MALNUTRITION ON PROTEIN METABOLISM IN MAN Unanswered Questions , 1984, The Lancet.
[41] D. J. Millward,et al. Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia. , 1983, Clinical physiology.
[42] D. Jones,et al. Human skeletal muscle function: description of tests and normal values. , 1977, Clinical science and molecular medicine.
[43] J. Bergström. Percutaneous Needle Biopsy of Skeletal Muscle in Physiological and Clinical Research , 1975 .
[44] J. Bergstrom. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. , 1975, Scandinavian journal of clinical and laboratory investigation.